Public Health
Volume 123, Issue 8 , Pages 534-539 , August 2009

Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China

  • R. Wang

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • Equal contributors.
    • ,
  • Y. Zhao

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • Equal contributors.
    • ,
  • X. He

      Affiliations

    • Health Service Faculty, Second Military Medical University, Shanghai, China
    • ,
  • X. Ma

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • ,
  • X. Yan

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • ,
  • Y. Sun

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • ,
  • W. Liu

      Affiliations

    • AstraZeneca R&D (Mölndal, Sweden), China
    • ,
  • Z. Gu

      Affiliations

    • AstraZeneca R&D (Mölndal, Sweden), China
    • ,
  • J. Zhao

      Affiliations

    • AstraZeneca R&D (Mölndal, Sweden), China
    • ,
  • J. He

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai 200433, China
    • Corresponding Author InformationCorresponding author. Tel./fax: +86 21 8187 1441.

Received 4 November 2008 ,Revised 15 May 2009 ,Accepted 17 June 2009.

References 

  1. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124–1134
  2. Schutta MH. Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions. J Cardiometab Syndr. 2007;2:124–130
  3. Saydah S, Eberhardt M, Rios-Burrows N, Williams D, Geiss L, Dorsey R. Prevalence of chronic kidney disease and associated risk factors – United States, 1999–2004. MMWR Morb Mortal Wkly Rep. 2007;56:161–165
  4. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269–1276
  5. Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol. 2002;5:188–199
  6. Bardage C, Isacson DG. Hypertension and health-related quality of life: an epidemiological study in Sweden. J Clin Epidemiol. 2001;54:172–181
  7. Aydemir O, Ozdemir C, Koroglu E. The impact of co-morbid conditions on the SF-36: a primary-care-based study among hypertensives. Arch Med Res. 2005;36:136–141
  8. Lam CL, Lauder IJ. The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Fam Pract. 2000;17:159–166
  9. Li W, Liu L, Puente JG, Li Y, Jiang X, Jin S, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens. 2005;23:1667–1676
  10. Cao Y, Yan X, Ma XQ, Wang R, Johansson S, Wallander MA, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol. 2008;8:37
  11. Wang R, Wu C, Zhao YF, Yan XY, Ma XQ, Wu MJ, et al. Health related quality of life measured by SF-36: a population-based study in Shanghai, China. BMC Public Health. 2008;8:292
  12. Zhou B, Coorperative Meta-Analysis Group of Working Group on Obesity in China . Prospective study for cut-off points of body mass index in Chinese adults. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:431–434
  13. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1167–1170
  14. Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalization. J Epidemiol Community Health. 2003;57:259–263
  15. Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. J Clin Epidemiol. 1998;51:1149–1158
  16. Wang HM, Beyer M, Gensichen J, Gerlach FM. Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey. BMC Public Health. 2008;8:246
  17. Fernández-López JA, Siegrist J, Hernández-Meía R, Broer M, Cueto-Espinar A. Study of quality of life on rural hypertensive patients. Comparison with the general population of the same environment. J Clin Epidemiol. 1994;47:1373–1380
  18. Krousel-Wood M, Re RN. Health status assessment in a hypertension section of an internal medicine clinic. Am J Med Sci. 1994;308:211–217
  19. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. JAMA. 1989;262:907–913
  20. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J. 1976;38:121–128
  21. Fryback DG, Dasbach EJ, Klein R, Klein BEK, Dorn N, Peterson K, et al. The Beaver Dam Health Outcomes Study; initial catalog of health-state quality factors. Med Decis Making. 1993;13:89–103
  22. Lawrence WF, Fryback DG, Martin PA, Klein R, Klein BE. Health status and hypertension: a population-based study. J Clin Epidemiol. 1996;49:1239–1245
  23. Persson L-O, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey. Evaluation of the clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol. 1998;51:1095–1103
  24. Battersby C, Hartley K, Fletcher AE, Markowe HJL, Styles W, Sapper H, et al. Quality of life in treated hypertension: a case–control community based study. J Hum Hypertens. 1995;9:981–986
  25. Kjellgren K, Ahlner J, Dahlof B, Gill H, Hedner T, Saljo R. Perceived symptoms amongst hypertensive patients in routine clinical practice – a population-based study. J Intern Med. 1998;244:325–332
  26. Moller L, Kristensen TS, Hollnagel H. Self rated health as a predictor of coronary heart disease in Copenhagen, Denmark. J Epidemiol Community Health. 1996;50:423–428
  27. Isacson D, Bingefors K, Carlson G. Analysing psychiatric side-effects of beta-blockers using large computerized data bases. Pharmacoepidemiol Drug Saf. 1995;4:335–341
  28. Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005;14:1311–1320
  29. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56
  30. Juniper EF. Effect of asthma on quality of life. Can Respir J. 1998;5(Suppl. A):77A–84A
  31. Dan AA, Kallman JB, Srivastava R, Younoszai Z, Kim A, Younossi ZM. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transpl. 2008;14:321–326
  32. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005;60:1571–1582
  33. Van der Waal JM, Terwee CB, van der Windt DA, Bouter LM, Dekker J. The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review. Qual Life Res. 2005;14:1141–1155
  34. Lahad A, Yodfar Y. Impact of comorbidity on well-being in hypertension: case control study. J Hum Hypertens. 1993;7:611–614

PII: S0033-3506(09)00166-8

doi: 10.1016/j.puhe.2009.06.009

Public Health
Volume 123, Issue 8 , Pages 534-539 , August 2009

Article Tools